FDC Ltd. | FDC | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 284 | 293 | 213 | 323 | 316 |
Short-term investment |
| 4,365 | 3,972 | 4,059 | 5,022 | 5,290 |
Accounts receivables |
| 761 | 817 | 875 | 1,237 | 1,105 |
Inventories |
| 1,372 | 1,605 | 1,738 | 2,100 | 2,149 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 300 | 537 | 515 | 589 | 477 |
Total current assets |
| 7,082 | 7,223 | 7,400 | 9,271 | 9,337 |
Gross property plant... |
| 6,712 | 6,685 | 6,757 | 6,548 | 6,700 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 6,712 | 6,685 | 6,757 | 6,548 | 6,700 |
Work in Progress |
| 34 | 99 | 124 | 239 | 192 |
Miscellaneous Investment |
| 602 | 801 | 1,849 | 1,685 | 2,740 |
Deferred income taxes |
| 0 | 120 | 149 | 158 | 240 |
Intangible assets |
| 98 | 81 | 64 | 62 | 44 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 45 | 43 | 55 | 166 | 308 |
Total non-current assets |
| 7,491 | 7,829 | 8,999 | 8,858 | 10,225 |
Total assets |
| 14,573 | 15,052 | 16,399 | 18,129 | 19,562 |
Short-term debt |
| 0 | 0 | 0 | 0 | 4 |
Accounts Payable... |
| 779 | 973 | 776 | 1,179 | 773 |
Provisions |
| 248 | 276 | 248 | 339 | 358 |
Taxes Payable |
| 46 | 178 | 150 | 145 | 131 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 70 |
Other current liabilities |
| 613 | 688 | 617 | 801 | 705 |
Total current liabilities |
| 1,687 | 2,115 | 1,791 | 2,463 | 2,040 |
Long-term debt |
| 7 | 6 | 5 | 3 | 2 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 174 | 152 | 133 | 92 | 109 |
Provisions |
| 4 | 4 | 4 | 3 | 4 |
Capital Leases |
| 0 | 0 | 0 | 93 | 68 |
Other longterm liabilities |
| 0 | 15 | 14 | 0 | 0 |
Total non-current liabilities |
| 184 | 176 | 156 | 192 | 183 |
Total liabilities |
| 1,871 | 2,291 | 1,946 | 2,655 | 2,223 |
Share Capital |
| 179 | 175 | 175 | 171 | 169 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 12,523 | 12,586 | 14,277 | 15,303 | 17,173 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | -2 |
Total Equity |
| 12,702 | 12,761 | 14,452 | 15,474 | 17,340 |
Total Liabilities and Equity |
| 14,573 | 15,052 | 16,399 | 18,129 | 19,562 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |